Mitomycin C and capecitabine: An additional option as an advanced line therapy in patients with metastatic colorectal cancer

Gil Mullin, Michal Sternschuss, Yosef Landman, Aaron Sulkes, Baruch Brenner*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Mitomycin C and capecitabine: An additional option as an advanced line therapy in patients with metastatic colorectal cancer'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology